# Chugai Z Score

CHGCF
Stock

## USD 22.860.000.00%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Chugai Pharmaceutical Piotroski F Score and Chugai Pharmaceutical Valuation analysis.
 Chugai

## Chugai Z Score Analysis

Chugai Pharmaceutical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 Z Score = Sum Of 5 Factors
More About Z Score | All Equity Analysis

### Current Chugai Pharmaceutical Z Score

1.0
Most of Chugai Pharmaceutical's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chugai Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 First Factor = 1.2 * ( Working Capital / Total Assets )
 Second Factor = 1.4 * ( Retained Earnings / Total Assets )
 Thrid Factor = 3.3 * ( EBITAD / Total Assets )
 Fouth Factor = 0.6 * ( Market Value of Equity / Total Liabilities )
 Fifth Factor = 0.99 * ( Revenue / Total Assets )
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
 Compare to competition Predict Chugai Pharmaceutical
In accordance with the company's disclosures, Chugai Pharmaceutical Co has a Z Score of 1.0. This is 85.19% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturersâ€”General industry. The z score for all United States stocks is 88.53% higher than that of the company.

## Chugai Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chugai Pharmaceutical's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc pink sheets which would be a good addition to a portfolio. Peer analysis of Chugai Pharmaceutical could also be used in its relative valuation, which is a method of valuing Chugai Pharmaceutical by comparing valuation metrics of similar companies.
Chugai Pharmaceutical is currently under evaluation in z score category among related companies.

## Chugai Fundamentals

 Return On Equity 0.31 % Return On Asset 0.21 % Profit Margin 0.32 % Operating Margin 0.46 % Current Valuation 39.4 B Shares Outstanding 1.64 B Shares Owned by Insiders 59.99 % Shares Owned by Institutions 18.61 % Price to Earning 19.49 X Price to Book 3.88 X Price to Sales 0.038 X Revenue 999.76 B Gross Profit 661.61 B EBITDA 419.43 B Net Income 303 B Cash and Equivalents 545.3 B Cash per Share 331.48 X Debt to Equity 0.011 % Current Ratio 3.21 X Book Value Per Share 795.51 X Cash Flow from Operations 279.63 B Earnings Per Share 1.62 X Price to Earnings To Growth 14.59 X Number of Employees 7.66 K Beta 0.56 Market Capitalization 43.43 B Total Asset 1538.69 B Retained Earnings 500.19 B Working Capital 435.19 B Current Asset 542.89 B Current Liabilities 107.7 B Z Score 1.0 Annual Yield 0.0291 % Net Asset 1538.69 B Last Dividend Paid 84.0

## About Chugai Pharmaceutical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chugai Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chugai Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chugai Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.

## Be your own money manager

Our tools can tell you how much better you can do entering a position in Chugai Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

## Did you try this?

### Run Equity Valuation Now

#### Equity Valuation

Check real value of public entities based on technical and fundamental data
 All  Next Launch Module

## Pair Trading with Chugai Pharmaceutical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chugai Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

### Moving against Chugai Pharmaceutical

 - 0.64 LULU Lululemon Athletica Earnings Call Tomorrow PairCorr
The ability to find closely correlated positions to Chugai Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chugai Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chugai Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chugai Pharmaceutical Co to buy it.
The correlation of Chugai Pharmaceutical is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chugai Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chugai Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chugai Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Continue to Chugai Pharmaceutical Piotroski F Score and Chugai Pharmaceutical Valuation analysis. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

## Complementary Tools for Chugai OTC Pink Sheet analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
 Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios Go Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios Go Insider ScreenerFind insiders across different sectors to evaluate their impact on performance Go Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges Go Risk-Return AnalysisView associations between returns expected from investment and the risk you assume Go Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets Go Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes Go Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities Go Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings Go Technical AnalysisCheck basic technical indicators and analysis based on most latest market data Go Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins Go Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. Go Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets Go
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.